Washington, Mar 19: A drug used to treat patients with glaucoma, a condition that raises the pressure inside the eye and can cause blindness, is now being marketed to make eyelashes longer, darker and thicker.

US pharmaceutical firm Allergan, which also markets popular wrinkle treatment Botox, is the company behind the drug, Latisse.

It uses the same formula as glaucoma drug Lumigan after scientists noticed the anti-blindness treatment boosted lashes.

"This is a new innovation for lashes. Latisse fulfills a significant and previously unmet aesthetic need in the marketplace," Discovery News quoted Frederick Beddingfield, Chief Medical Officer for Allergan, as saying.

Washington, Mar 19: Depression is often associated with negative thoughts and emotions, but a new study has suggested that the real trouble with depressed people is the failure to appreciate positive experiences.

Researchers at Ohio State University found that depressed and non-depressed people were about equal in their ability to learn negative information that was presented to them.

However, depressed people weren’t nearly as successful at learning positive information, as were their non-depressed counterparts.

Washington, Mar 19: An Australian

Washington, Mar 19: A new study has shown that parents are likely to misperceive their child’s weight – especially those parents who are overweight themselves.

Looking at several studies that examine parental perceptions of childhood obesity generated from the United Kingdom, Australia, Italy, and the United States, Jessica Doolen, MSN, FNP, Patricia T. Alpert, DrPH, APN, FAANP, and Sally K. Miller, PhD, APN, FAANP, found that parents were more likely to misperceive their child’s weight, regardless of the child’s age.

Washington, Mar 19: Queen’s University researchers have found that kids who exercise in bouts of activity lasting five minutes or longer are less likely to become obese than those whose activity levels are more sporadic and typically last less than five minutes each.

Washington, Mar 19: A new study has revealed that smokers who refuse to quit the habit despite being diagnosed with lung cancer experience higher levels of pain from the disease than non-smokers and former smokers.

Researchers at Duke University surveyed some 900 lung cancer patients and classified 17 percent of them as persistent smokers.

The aim of the study was to assess the relationship of smoking status after a diagnosis of lung cancer with ratings of usual pain.